Truvestments Capital’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.73K | Hold |
125
| – | – | ﹤0.01% | 718 |
|
|
2025
Q1 | $6.02K | Hold |
125
| – | – | ﹤0.01% | 735 |
|
|
2024
Q4 | $6.33K | Hold |
125
| – | – | ﹤0.01% | 668 |
|
|
2024
Q3 | $7.97K | Buy |
+125
| New | +$7.97K | ﹤0.01% | 613 |
|
|
2024
Q2 | – | Sell |
-125
| Closed | -$7.19K | – | 278 |
|
|
2024
Q1 | $7.19K | Hold |
125
| – | – | ﹤0.01% | 521 |
|
|
2023
Q4 | $7.13K | Hold |
125
| – | – | ﹤0.01% | 546 |
|
|
2023
Q3 | $6K | Hold |
125
| – | – | ﹤0.01% | 494 |
|
|
2023
Q2 | $6.5K | Sell |
125
-25
| -17% | -$1.3K | ﹤0.01% | 502 |
|
|
2023
Q1 | $8.13K | Sell |
150
-10
| -6% | -$542 | ﹤0.01% | 456 |
|
|
2022
Q4 | $9.23K | Sell |
160
-30
| -16% | -$1.73K | 0.01% | 464 |
|
|
2022
Q3 | $9K | Sell |
190
-10
| -5% | -$474 | 0.01% | 417 |
|
|
2022
Q2 | $10K | Buy |
+200
| New | +$10K | 0.01% | 409 |
|
|
2022
Q1 | – | Sell |
-200
| Closed | -$16K | – | 224 |
|
|
2021
Q4 | $16K | Hold |
200
| – | – | 0.01% | 361 |
|
|
2021
Q3 | $19K | Hold |
200
| – | – | 0.01% | 320 |
|
|
2021
Q2 | $20K | Sell |
200
-250
| -56% | -$25K | 0.01% | 319 |
|
|
2021
Q1 | $38K | Buy |
450
+200
| +80% | +$16.9K | 0.02% | 308 |
|
|
2020
Q4 | $22K | Hold |
250
| – | – | 0.02% | 348 |
|
|
2020
Q3 | $17K | Hold |
250
| – | – | 0.02% | 234 |
|
|
2020
Q2 | $18K | Hold |
250
| – | – | 0.02% | 316 |
|
|
2020
Q1 | $11K | Buy |
+250
| New | +$11K | 0.01% | 332 |
|
|
2019
Q4 | – | Sell |
-750
| Closed | -$32K | – | 188 |
|
|
2019
Q3 | $32K | Hold |
750
| – | – | 0.02% | 324 |
|
|
2019
Q2 | $39K | Hold |
750
| – | – | 0.03% | 313 |
|
|
2019
Q1 | $42K | Buy |
+750
| New | +$42K | 0.03% | 304 |
|
|
2018
Q3 | $64K | Buy |
+920
| New | +$64K | 0.03% | 332 |
|